NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tronox Holdings plc ("Tronox" or "the Company") (NYSE:TROX). Investors who purchased Tronox securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TROX. Investigation […]

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Albany International Corp. ("Albany" or "the Company") (NYSE:AIN). Investors who purchased Albany securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AIN.

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of agilon health, inc. ("Agilon" or "the Company") (NYSE:AGL). Investors who purchased Agilon securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AGL. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fluor Corporation ("Fluor" or "the Company") (NYSE:FLR). Investors who purchased Fluor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FLR. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lineage, Inc. ("Lineage" or "the Company") (NASDAQ:LINE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ:EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EXEL. Investigation Details

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CHTR.

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO). Investors who purchased Novo Nordisk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortinet, Inc. ("Fortinet" or "the Company") (NYSE:FTNT). Investors who purchased Fortinet securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FTNT. Investigation Details

LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards today announced that Longevity15(R) from Pet's Best Life has been selected as “Overall Dog Health Product of the Year.” The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet care